Armed with a $190 million order from the U.S. Department of Health and Human Services, Sanofi Pasteur could begin production of a swine flu vaccine at one of its two Swiftwater facilities as soon as next month.
Announcing the news Monday, Sanofi noted the order was issued under an existing pandemic stockpile contract with the U.S.
News comes just two weeks after the U.S. Food and Drug Administration issued a license for Sanofi's new, $150 million, 140,000-square-foot vaccine manufacturing plant at Swiftwater. That's where initial work would begin, while an existing plant at the complex continues work on seasonal flu vaccine. Ultimately, both could produce the new vaccine.
(Emphasis added)
That is the production of the swine flu vaccine as soon as next month in June. Just previously posted on this site, in an article on May 20th, Sanofi was waiting to get the seed strain. And it would take at least until September to begin production.
So how is it that a company can go from 6 days ago not having a seed strain to producing the vaccine next month?
Related Threads:
Who had the Seed Strain and how did GlaxoSmithKline Get the Orders
Mexico City ends swine flu alert, no cases in week
Protein Sciences Talking With Mexican Government About Making Flu Vaccine
In About Two Weeks a Major Development Will Occur in Mexico With Regard to the Flu Bug
I believe at this point that miraculously a vaccine will be reported to have been made or is close to being made and a truce will be made behind the scene with the cartels. April 30th, 2009
Posts
No comments:
Post a Comment